Revenue cycle · Clinical documentation integrity AI
SmarterDx
SmarterDx provides clinical documentation integrity AI that reviews charts after the encounter to find missed diagnoses, specificity gaps, and denial risk for health-system CDI and coding teams. It is not an ambient scribe.
Strong fit
- Health systems that want AI to find missed CDI and coding opportunities after the chart is written
- Revenue integrity leaders comparing clinical AI documentation tools against traditional concurrent CDI staffing alone
- Buyers that need measurable denial prevention and case-mix capture, not another ambient scribe
Weak fit
- Small ambulatory clinics that only need visit coding for a handful of physicians
- Teams shopping ambient scribes for note creation rather than post-encounter CDI review
- Organizations that refuse cloud clinical AI on EHR data
Bottom line
SmarterDx earns a Recommend at the top of this mid-market revenue-integrity board for health systems that already chart in a major EHR and still leave CDI money on the table. The product reads clinical documentation after the encounter and surfaces missed diagnoses, specificity gaps, and denial risk rather than writing the note for the clinician. Public customer stories cite multi-million-dollar annual revenue recovery and strong ROI claims versus adding CDI FTEs alone. Third-party estimates put revenue near $70M with a few hundred employees after New Mountain Capital's growth investment, above our $5-50M prefer band and still under the hard ceiling. Implementation is an EHR data and CDI workflow project, not a weekend install. Pricing is enterprise quote-based. Score sits above mid-market autonomous coding tools when the buying problem is inpatient CDI completeness rather than professional-fee code suggestions.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
SmarterDx is a New York clinical AI company founded by physician CEO Michael Gao. The platform reviews inpatient and related documentation after the chart is written to flag missed diagnoses, specificity gaps, and denial risk for CDI and coding teams.
It is revenue-integrity AI, not an ambient scribe and not a patient billing portal. Compare Nym when the buy is autonomous medical coding for professional fees, Aptarro when you want mid-market AI RCM across claims workflows, and MDaudit when the core need is audit and compliance rather than concurrent CDI capture.
Score reflects strong outcome stories on case-mix and denial prevention, with softer marks on pricing clarity typical of enterprise clinical AI.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| SmarterDx | 7.6 | 7.2 |
| Inbox Health | 7.4 | 7.1 |
| Collectly | 7.4 | 7.2 |
| MDaudit | 7.4 | 7.1 |
| Enter Health | 7.3 | 7.0 |
| Candid Health | 7.2 | 6.9 |
| Aptarro | 7.0 | 6.8 |
| PatientPay | 7.0 | 7.0 |
| Mentaya | 6.9 | 7.0 |
| MD Clarity | 6.9 | 6.7 |
| Nym | 6.6 | 6.4 |
| Rivia Health | 6.5 | 6.4 |
Pricing
| Item | Detail |
|---|---|
| Model | Enterprise SaaS for clinical documentation integrity and revenue recovery AI; quote-based with health-system contracts. |
| What usually drives cost | Facility volume, modules (CDI, coding assist, denials), EHR integration scope, and support tier. |
| What to ask in diligence | Expected annual contract value at your discharge volume, including implementation and ongoing CDI workflow support. |
| Published pricing | No public list price; enterprise quotes only. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get SmarterDx to function | |
| CDI and coding owners named | AI findings die without reviewers. |
| EHR data access scoped | No feed means no recommendations. |
| Baseline denial and CMI metrics | You cannot prove ROI without a baseline. |
| Privacy and BA review complete | Clinical AI stalls in security review. |
| Physician advisor path for disputes | Coders alone cannot resolve clinical fights. |
| What will maximize your value | |
| Pilot one service line first | Enterprise day one multiplies noise. |
| Measure recovered revenue at 90 days | Prove CDI lift. |
| Retire overlapping concurrent review tools | Duplicate queues confuse staff. |
| Deal-breakers | |
| Ambient scribe is the only need | |
| No EHR data sharing allowed | |
| No CDI owners available | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Security and data mapping | 4-8 weeks |
| 2 | Pilot service line | 6-12 weeks |
| 3 | Scale and tune | 8-16 weeks |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category actually buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.